Galectin-3 and CD44v6 isoforms in the preoperative evaluation of thyroid nodules
| Autor: | Pier Giorgio Natali, Armando Bartolazzi, Fabrizio Del Prete, Alessandra Gasbarri, Marco Paolo Martegani, Teresa Lucante |
|---|---|
| Rok vydání: | 1999 |
| Předmět: |
Thyroid nodules
Adenoma Cancer Research Pathology medicine.medical_specialty Galectin 3 Malignancy Sensitivity and Specificity Malignant transformation Diagnosis Differential Preoperative Care medicine Endocrine system Humans Protein Isoforms Thyroid Neoplasms Thyroid Nodule Thyroid cancer business.industry Reverse Transcriptase Polymerase Chain Reaction Thyroid medicine.disease Antigens Differentiation medicine.anatomical_structure Hyaluronan Receptors Oncology Cytopathology Immunohistochemistry business |
| Zdroj: | Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 17(11) |
| ISSN: | 0732-183X |
| Popis: | PURPOSE: Thyroid cancer is the most frequently occurring endocrine malignancy; however, preoperative diagnosis of some lesions, in particular those with follicular histology, is difficult, and a consistent number of nototherwise-specified “follicular nodules” are surgically resected more for diagnosis than therapeutic purposes. In this study, we investigated whether the lectin-related molecules CD44v6 and galectin-3, the expression of which is altered during deregulated cell growth and malignant transformation, could be potential markers for improving the diagnostic accuracy of conventional cytology. MATERIALS AND METHODS: A comparative immuno-chemical and molecular analysis was performed on 157 thyroid specimens representative of normal, benign, and malignant tissues, and on 36 cytologic samples obtained preoperatively by fine-needle aspiration biopsy from nonselected patients with palpable thyroid nodules. RESULTS: Normal thyrocytes did not express galectin-3 nor CD44v6. Although the expression of CD44v6 isnegligible in thyroiditis, these molecules are variably detected in benign and malignant proliferative lesions. Interestingly, galectin-3 is never expressed in benign lesions, but it is invariably detected in cancers. A comparative evaluation of CD44v6 and galectin-3 expression in thyroid malignancies demonstrated that these molecules are coexpressed at the messenger RNA and protein level in almost all lesions. CONCLUSION: Our findings suggest that CD44v6 and galectin-3 could be potential markers to preoperatively identify malignant transformed thyrocytes. Immunodetection of these molecules on cytologic specimens obtained by fine-needle aspiration biopsy is an accurate and improved method for selecting, on a molecular basis, those nodular lesions of the thyroid gland that need to be surgically resected. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|